The Direct and Long-Term Effects of Raloxifene as Adjunctive Treatment for Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Clinical Trial

BACKGROUND AND HYPOTHESIS: Several studies suggest that raloxifene, a selective estrogen receptor modulator, improves symptoms and cognition in post-menopausal women with Schizophrenia-Spectrum Disorders (SSD). We aimed to assess the effects of adjunctive raloxifene in women and men with SSD. STUDY...

Descripción completa

Detalles Bibliográficos
Autores principales: Brand, Bodyl A, de Boer, Janna N, Marcelis, Machteld C, Grootens, Koen P, Luykx, Jurjen J, Sommer, Iris E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686337/
https://www.ncbi.nlm.nih.gov/pubmed/37116866
http://dx.doi.org/10.1093/schbul/sbad058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686337/
https://www.ncbi.nlm.nih.gov/pubmed/37116866
http://dx.doi.org/10.1093/schbul/sbad058

Ejemplares similares